Molecular characterization of Staphylococcus aureus carrying the panton-valentine leucocidin genes in northern Spain

Journal of Infection

Volumn 64, Issue 1, 2012, Pages 47-53

  Marimón, José M ^a,b   Villar, María ^a   García Arenzana, José M ^a   Caba, Idoia de la ^a   Pérez Trallero, Emilio ^a,b,c  

^a BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Dermal infections; Methicillin resistant; Multilocus sequence type; PVL; SCCmec; Spa typing

Indexed keywords

BETA LACTAM; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; PANTON VALENTINE LEUKOCIDIN; PSEUDOMONIC ACID; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARCA GENE; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLINICAL ARTICLE; GENE IDENTIFICATION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; PVL GENE; SPAIN; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; EXOTOXINS; HUMANS; INFANT; LEUKOCIDINS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; SPAIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84455202382     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.10.010     Document Type: Article

References (32)

1. Kaneko J., Kimura T., Narita S., Tomita T., Kamio Y. Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriopharge phiPVL carrying Panton-Valentine leukocidin genes. Gene 1998, 215:57-67.
2. Lina G., Piémont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
3. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003, 9:978-984.
4. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey R.B., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355:666-674.
5. Del Giudice P., Blanc V., Durupt F., Bes M., Martinez J.P., Counillon E., et al. Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. Br J Dermatol 2006, 154:118-124.
6. Manzur A., Dominguez A.M., Pujol M., González M.P., Limon E., Hornero A., et al. Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect 2008, 14:377-380.
7. Tristan A., Bes M., Meugnier H., Lina G., Bozdogan B., Courvalin P., et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007, 13:594-600.
8. Mendes R.E., Sader H.S., Deshpande L.M., Diep B.A., Chambers H.F., Jones R.N. Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid. J Clin Microbiol 2010, 48:568-574.
9. Goering R.V., Shawar R.M., Scangarella N.E., O'Hara F.P., Amrine-Madsen H., West J.M., et al. Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. J Clin Microbiol 2008, 46:2842-2847.
10. Kennedy A.D., Otto M., Braughton K.R., Whitney A.R., Chen L., Mathema B., et al. Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A 2008, 105:1327-1332.
11. Diep B.A., Gill S.R., Chang R.F., Phan T.H., Chen J.H., Davidson M.G., et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006, 367:731-739.
12. Clinical and Laboratory Standards Institute Performance Standards for antimicrobial susceptibility testing: twentieth informational supplement M100-S20 2010, CLSI, Wayne, PA, USA.
13. Saïd-Salim B., Mathema B., Braughton K., Davis S., Sinsimer D., Eisner W., et al. Differential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 2005, 43:3373-3379.
14. Shopsin B., Gomez M., Montgomery S.O., Smith D.H., Waddington M., Dodge D.E., et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999, 37:3556-3563.
15. Oliveira D.C., de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002, 46:2155-2161.
16. Milheiriço C., Oliveira D.C., de Lencastre H. Multiplex PCR strategy for subtyping the staphylococcal cassette chromosome mec type IV in methicillin-resistant Staphylococcus aureus: SCCmec IV multiplex. J Antimicrob Chemother 2007, 60:42-48.
17. Campbell S.J., Deshmukh H.S., Nelson C.L., Bae I.G., Stryjewski M.E., Federspiel J.J., et al. Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections. J Clin Microbiol 2008, 46:678-684.
18. Trallero E.P., Arenzana J.G., Castañeda A.A., Grisolia L.P. Unusual multiresistant Staphylococcus aureus in a newborn nursery. Am J Dis Child 1981, 135:689-692.
19. Vindel A., Cuevas O., Cercenado E., Marcos C., Bautista V., Castellares C., et al. Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods. J Clin Microbiol 2009, 47:1620-1627.
20. Alkiza M.E., Arriola E., Basterretxea M., Díaz I., Esparza M.H., García-Arenzana J.M., et al. Practice guidelines in methicillin-resistant Staphylococcus aureus in gerontological centres, nursing homes and medium to long-term care units. Rev Esp Geriatr Gerontol 2004, 39:329-341.
21. Blanco R., Tristan A., Ezpeleta G., Larsen A.R., Bes M., Etienne J., et al. Molecular epidemiology of Panton-Valentine leukocidin-positive Staphylococcus aureus in Spain: emergence of the USA300 clone in an autochthonous population. J Clin Microbiol 2011, 49:433-436.
22. Wannet W.J., Spalburg E., Heck M.E., Pluister G.N., Tiemersma E., Willems R.J., et al. Emergence of virulent methicillin-resistant Staphylococcus aureus strains carrying Panton-Valentine leucocidin genes in The Netherlands. J Clin Microbiol 2005, 43:3341-3345.
23. Cercenado E., Cuevas O., Marín M., Bouza E., Trincado P., Boquete T., et al. Community-acquired methicillin-resistant Staphylococcus aureus in Madrid, Spain: transcontinental importation and polyclonal emergence of Panton-Valentine leukocidin-positive isolates. Diagn Microbiol Infect Dis 2008, 61:143-149.
24. Larsen A., Stegger M., Goering R., Sorum M., Skov R. Emergence and dissemination of the methicillin resistant Staphylococcus aureus USA300 clone in Denmark (2000-2005). Euro Surveill 2007, 12:22-24.
25. Goering R.V., McDougal L.K., Fosheim G.E., Bonnstetter K.K., Wolter D.J., Tenover F.C. Epidemiologic distribution of the arginine catabolic mobile element among selected methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates. J Clin Microbiol 2007, 45:1981-1984.
26. Baranovich T., Zaraket H., Shabana, Nevzorova V., Turcutyuicov V., Suzuki H. Molecular characterization and susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from hospitals and the community in Vladivostok, Russia. Clin Microbiol Infect 2010, 16:575-582.
27. Monecke S., Slickers P., Ellington M.J., Kearns A.M., Ehricht R. High diversity of Panton-Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus. Clin Microbiol Infect 2007, 13:1157-1164.
28. Han L.Z., Ho P.L., Ni Y.X., Zhang H., Jiang Y.Q., Chu H.Q., et al. Panton-Valentine leukocidin-positive MRSA, Shanghai. Emerg Infect Dis 2010, 16:731-733.
29. Aires-de-Sousa M., Conceição T., de Lencastre H. Unusually high prevalence of nosocomial Panton-Valentine leukocidin-positive Staphylococcus aureus isolates in Cape Verde Islands. J Clin Microbiol 2006, 44:3790-3793.
30. Breurec S., Fall C., Pouillot R., Boisier P., Brisse S., Diene-Sarr F., et al. Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes. Clin Microbiol Infect 2011, 17:633-639.
31. Hochedez P., Canestri A., Lecso M., Valin N., Bricaire F., Caumes E. Skin and soft tissue infections in returning travelers. Am J Trop Med Hyg 2009, 80:431-434.
32. Otto M.A. MRSA-terious enemy among us: end of the PVL controversy?. Nat Med 2011, 17:169-170.